Pharmaceutical compounding is governed by a combination of federal and state regulations to ensure patient safety and medication quality. At the federal level, laws such as the Food, Drug, and Cosmetic Act (FDCA) and the Drug Quality and Security Act (DQSA) set crucial standards. The DQSA, enacted in 2013, established requirements specifically for outsourcing facilities that produce compounded drugs in larger volumes, mandating compliance with Current Good Manufacturing Practices (CGMP). These facilities undergo routine inspections by the Food and Drug Administration (FDA).
Compounded medications tailored for home care include both sterile and non-sterile formulations, carefully prepared to meet individual patient needs. Non-sterile preparations are among the most common and include topical creams, ointments, gels, capsules, liquids, troches, and sprays. These forms are extensively used for conditions such as skin issues, pain relief, and pediatric health, allowing for custom dosages and ingredient adjustments.
When a patient needs a medication that is not commercially available in the right dose, formulation, or combination, a sterile compounding pharmacy creates it. Sterile compounding is the process of preparing customized, injectable or infusible medications, IV solutions, eye drops, inhalation solutions, in a controlled, contamination-free environment. Pharmko's sterile compounding services are at the core of what makes specialty pharmacy different from a retail pharmacy. Every IV medication we prepare is custom-compounded, validated, and released by a licensed pharmacist before it reaches a patient. What Makes Compounding 'Sterile'? The word 'sterile' refers to the absence of viable microorganisms, bacteria, fungi, endotoxins, in the final product. This is non-negotiable for any medication injected into or infused through the body. A contaminated IV solution can cause severe bloodstream infections, sepsis, or death. Achieving sterility requires: A controlled cleanroom environment (ISO Class 5 or better at the point of compounding) Positive or negative air pressure depending on the type of medication being prepared Gowning, gloving, and aseptic technique by trained pharmacy staff Validated sterilization methods (filtration, terminal sterilization) appropriate for each formulation Environmental and personnel monitoring to detect contamination risks before they reach patients How Sterile Compounding Differs from Retail Pharmacy A retail pharmacy dispenses commercially manufactured medications in their existing forms — tablets, capsules, pre-made liquids. A sterile compounding pharmacy like Pharmko creates medications that either do not exist commercially, are no longer commercially available, or must be customized for a specific patient. Examples of why sterile compounding is necessary: A patient needs a specific antibiotic concentration not available in commercial vials TPN must be formulated individually based on the patient's weight, labs, and nutritional requirements — no pre-made product covers every case A pediatric patient needs a lower concentration of an IV medication than any commercial product offers IV antibiotics must be prepared in specific volumes and concentrations for OPAT patients based on the prescribed regimen What Is USP <797>? USP <797> is the United States Pharmacopeia chapter that sets the standards for sterile compounding. It defines the environmental requirements, beyond-use dating, testing, personnel training, and quality systems that a pharmacy must maintain to legally compound sterile preparations. Compliance with USP <797> is required by state pharmacy boards and enforced through inspections. Not all compounding pharmacies meet these standards — patients and providers should verify that any pharmacy preparing IV medications is operating in full USP <797> compliance. For a detailed breakdown of what USP <797> and the newer USP <800> standard mean for patient safety, see our guide on sterile compounding safety standards . How Pharmko's Compounding Process Works Pharmko operates a state-of-the-art USP <797> compliant sterile compounding facility. Every product we prepare goes through: Pharmacist review of the prescription for appropriateness, compatibility, and dosing Preparation by trained pharmacy technicians in an ISO Class 5 laminar airflow workbench or biological safety cabinet In-process and final product checks by a licensed pharmacist Sterility testing or filtration validation where required Cold-chain delivery to the patient or dialysis clinic within validated stability windows Why It Matters for Home Infusion Patients Every IV therapy delivered through Pharmko's home infusion services is compounded in our sterile facility. This means patients at home receive the same quality-controlled, pharmacist-verified products they would receive in a hospital — not medications assembled at the bedside or sourced from uncredentialed suppliers. → Contact Pharmko to learn more about our compounding services: 1-877-540-2003
Pharmko provides home infusion therapy across Florida, IV antibiotics, IVIG, TPN, IDPN, and specialty medications. Licensed, accredited, and available 24/7 statewide.
Pharmko provides home infusion therapy across Texas — IV antibiotics, IVIG, TPN, IDPN, and specialty medications. Licensed, accredited, and available 24/7 statewide.
Learn how phosphate binders work for dialysis and CKD patients, the different types available, how they fit into a renal care plan, and how Pharmko supports dialysis centers with consistent supply.
Learn how home infusion therapy supports autoimmune disease management,from IVIG for immune deficiencies to biologic infusions for inflammatory conditions. Pharmko serves 22+ states.
Learn the differences between subcutaneous and IV infusion delivery routes,how each works, which therapies use them, and how to choose the right option for your treatment.
Learn how home milrinone infusion works for advanced heart failure patients, who qualifies for palliative milrinone therapy, what to expect, and how Pharmko supports safe at-home cardiac care.
Learn how home infusion therapy for Crohn's disease works, including Remicade (infliximab) and other biologics. Who qualifies, what each infusion involves, and how Pharmko supports ongoing care.
Malnutrition affects up to 75% of hemodialysis patients. Learn to recognize protein-energy wasting, understand when IDPN is clinically indicated, and how Pharmko supports renal nutrition management.
Learn how intradialytic parenteral nutrition (IDPN) works, who qualifies based on albumin levels and nutritional status, and how Pharmko delivers IDPN for dialysis patients.
